AAAAAA
Results:
1-24
|
Results: 24
Authors:
COLLINS RH
PINEIRO LA
AGURA ED
FAY JW
Citation: Rh. Collins et al., TREATMENT OF T-PROLYMPHOCYTIC LEUKEMIA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21(6), 1998, pp. 627-628
Authors:
COLLINS RH
SHPILBERG O
DROBYSKI WR
PORTER DL
GIRALT S
CHAMPLIN R
GOODMAN SA
WOLFF SN
HU W
VERFAILLIE C
LIST A
DALTON W
OGNOSKIE N
CHETRIT A
ANTIN JH
NEMUNAITIS J
Citation: Rh. Collins et al., DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 15(2), 1997, pp. 433-444
Authors:
COLLINS RH
SACKLER M
PITCHER CJ
WALDROP SL
KLINTMALM GB
JENKINS R
PICKER LJ
Citation: Rh. Collins et al., IMMUNE RECONSTITUTION WITH DONOR-DERIVED MEMORY EFFECTOR T-CELLS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION/, Experimental hematology, 25(2), 1997, pp. 147-159
Authors:
COLLINS RH
Citation: Rh. Collins, AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Lancet, 349(9055), 1997, pp. 881-881
Authors:
BROWN RA
WOLFF SN
FAY JW
PINEIRO L
COLLINS RH
LYNCH JP
STEVENS D
GREER J
HERZIG RH
HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP, Leukemia & lymphoma, 22(3-4), 1996, pp. 271-277
Authors:
STONE MJ
SAUSVILLE EA
FAY JW
HEADLEE D
COLLINS RH
FIGG WD
STETLERSTEVENSON M
JAIN V
JAFFE ES
SOLOMON D
LUSH RM
SENDEROWICZ A
GHETIE V
SCHINDLER J
UHR JW
VITETTA ES
Citation: Mj. Stone et al., A PHASE-I STUDY OF BOLUS VERSUS CONTINUOUS-INFUSION OF THE ANTI-CD19 IMMUNOTOXIN, IGG-HD37-DGA, IN PATIENTS WITH B-CELL LYMPHOMA, Blood, 88(4), 1996, pp. 1188-1197
Authors:
COLLINS RH
SACKLER M
PITCHER CJ
WALDROP SL
KLINTMALM GB
JENKINS R
PICKER LJ
Citation: Rh. Collins et al., IMMUNE RECONSTITUTION WITH DONOR-DERIVED MEMORY EFFECTOR T-CELLS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION/, Blood, 88(10), 1996, pp. 448-448
Authors:
ARROWSMITH ER
GOODMAN SA
COLLINS RH
WOOD S
GREER JP
EDWARDS J
STEIN RS
BRANDT SA
PINEIRO LA
STEIN B
KALLIANPUR A
FAY JW
WOLFF SN
Citation: Er. Arrowsmith et al., MIS-MATCHED (MM) RELATED ALLOGENEIC (ALLO) BONE-MARROW TRANSPLANTATION (BMT) - ANALYSIS OF PROGNOSTIC FACTORS AND LONG-TERM SURVIVAL (LTS), Blood, 88(10), 1996, pp. 1045-1045
Authors:
FAY JW
WINGARD JR
ANTIN JH
COLLINS RH
PINEIRO LA
BLAZAR BR
SARAL R
BIERER BE
PRZEPIORKA D
FITZSIMMONS WE
MAHER RM
WEISDORF DJ
Citation: Jw. Fay et al., FK506 (TACROLIMUS) MONOTHERAPY FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HISTOCOMPATIBLE SIBLING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 87(8), 1996, pp. 3514-3519
Authors:
COLLINS RH
KLINTMALM GB
Citation: Rh. Collins et Gb. Klintmalm, APLASTIC-ANEMIA AFTER LIVER-TRANSPLANTATION, Hepatology, 22(3), 1995, pp. 1011-1012
Authors:
ROSS AA
MILLER GW
MOSS TJ
KAHN DG
WARNER NE
SWEET DL
LOUIE KG
SCHNEIDERMANN E
PECORA AL
MEAGHER RC
HERZIG RH
COLLINS RH
FAY JW
Citation: Aa. Ross et al., IMMUNOCYTOCHEMICAL DETECTION OF TUMOR-CELLS IN BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM PATIENTS WITH OVARIAN-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 929-933
Authors:
FAY JW
NASH RA
WINGARD JR
PRZEPIORKA D
COLLINS RH
ANASETTI C
DEVINE SM
PINEIRO LA
STORB RF
ARO RM
FITZSIMMONS WE
Citation: Jw. Fay et al., FK 506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER UNRELATED DONOR MARROW TRANSPLANTATION, Transplantation proceedings, 27(1), 1995, pp. 1374-1374
Authors:
COLLINS RH
PINEIRO LA
NEMUNAITIS JJ
JAIN VK
WAXMAN D
MILLER WV
FAY JW
Citation: Rh. Collins et al., TRANSFUSION OF DONOR BUFFY COAT CELLS IN THE TREATMENT OF PERSISTENT OR RECURRENT MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Transfusion, 35(11), 1995, pp. 891-898
Authors:
BROWN RA
WOLFF SN
FAY JW
PINEIRO L
COLLINS RH
LYNCH JP
STEVENS D
GREER J
HERZIG RH
HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP, Blood, 85(5), 1995, pp. 1391-1395
Authors:
COLLINS RH
Citation: Rh. Collins, CD34(+) SELECTED CELLS IN CLINICAL TRANSPLANTATION, Stem cells, 12(6), 1994, pp. 577-585
Authors:
NIKAEIN A
POOLE T
FISHBECK R
ORDONEZ G
DOMBRAUSKY L
STONE MJ
COLLINS RH
FAY JW
Citation: A. Nikaein et al., CHARACTERIZATION OF SKIN-INFILTRATING CELLS DURING ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION USING UNRELATED MARROW DONORS, Human immunology, 40(1), 1994, pp. 68-76
Authors:
COLLINS RH
Citation: Rh. Collins, TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN PREVENTION OF LIVER ALLOGRAFT-REJECTION, Lancet, 344(8927), 1994, pp. 949-949
Authors:
NIKAEIN A
COLLINS RH
KLINTMALM G
POOLE T
FAY JW
STONE MJ
Citation: A. Nikaein et al., IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 57(4), 1994, pp. 637-640
Authors:
COLLINS RH
FAY JW
Citation: Rh. Collins et Jw. Fay, TREATMENT OF LEUKEMIA IN RELAPSE AFTER BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 330(9), 1994, pp. 645-645
Authors:
FAY JW
LAZARUS H
HERZIG R
SAEZ R
STEVENS DA
COLLINS RH
PINEIRO LA
COOPER BW
DICESARE J
CAMPION M
FELSER JM
HERZIG G
BERNSTEIN SH
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/, Blood, 84(7), 1994, pp. 2151-2157
Authors:
FAY JW
PINEIRO L
COLLINS RH
STEIN B
ARO RM
FITZSIMMONS WE
Citation: Jw. Fay et al., FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER UNRELATED MARROW DONOR (UMD) TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000708-10000708
Authors:
FAY JW
FELSER J
LAZARUS HM
HERZIG R
SAEZ R
STEVENS D
COLLINS RH
PINERO L
COOPER B
HERZIG GP
CAMPION M
DICESARE J
BERNSTEIN SH
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 (RHIL-3) AND RHGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN UPDATE OF THE PHASE-I II TRIAL/, Blood, 82(10), 1993, pp. 10000287-10000287
Authors:
FAY JW
COLLINS RH
PINEIRO LA
NEMUNAITIS JJ
ARO R
FITZSIMMONS W
Citation: Jw. Fay et al., FK506 TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW TRANSPLANTATION (AMT) USING UNRELATED MARROW DONORS (UMD)-A PHASE-II STUDY, Blood, 82(10), 1993, pp. 10000420-10000420
Authors:
WOLFF SN
FAY JW
HERZIG RH
GREER JP
DUMMER S
BROWN RA
COLLINS RH
STEVENS DA
HERZIG GP
Citation: Sn. Wolff et al., HIGH-DOSE WEEKLY INTRAVENOUS IMMUNOGLOBULIN TO PREVENT INFECTIONS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION OR SEVERE MYELOSUPPRESSIVE THERAPY - A STUDY OF THE AMERICAN-BONE-MARROW-TRANSPLANT-GROUP, Annals of internal medicine, 118(12), 1993, pp. 937-942
Risultati:
1-24
|